TregTherapeutics Inc.
Research - Chapel Hill, North Carolina, United States
TregTherapeutics Inc. Employees
TregTherapeutics Inc. Details
TregTherapeutics Inc. is a preclinical stage company focused on the treatment and cure of multiple sclerosis. The objective of the TregTherapeutics tolerogenic vaccine is to reverse the inflammatory T cell immune attack in demyelinating lesions of an MS patient, and subsequently, to create an anti-inflammatory tolerogenic response within that patient.
Website:
http://www.tregtherapeutics.com
Employees:
1
HQ:
Location:
Chapel Hill, North Carolina, United States
Revenue:
TregTherapeutics Inc. Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly
Hosting
GoDaddy Hosting